MARSHALL WACE, LLP - CANTEL MEDICAL CORP ownership

CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 255 filers reported holding CANTEL MEDICAL CORP in Q1 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CANTEL MEDICAL CORP
ValueSharesWeighting
Q1 2021$3,296,000
+540.0%
41,285
+531.3%
0.02%
+400.0%
Q4 2020$515,000
-73.1%
6,540
-85.0%
0.00%
-75.0%
Q3 2020$1,915,000
+743.6%
43,578
+589.4%
0.01%
+500.0%
Q1 2020$227,000
-17.8%
6,321
+84.9%
0.00%0.0%
Q2 2019$276,000
+51.6%
3,418
+25.6%
0.00%
+100.0%
Q1 2019$182,000
-97.6%
2,722
-97.4%
0.00%
-98.7%
Q4 2018$7,688,000
-66.8%
103,265
-58.9%
0.08%
-20.4%
Q3 2018$23,138,000
+5194.7%
251,334
+4384.1%
0.10%
+3166.7%
Q3 2016$437,000
-85.3%
5,605
-87.1%
0.00%
-88.0%
Q2 2016$2,979,000
+979.3%
43,340
+744.2%
0.02%
+525.0%
Q2 2015$276,0005,1340.00%
Other shareholders
CANTEL MEDICAL CORP shareholders Q1 2019
NameSharesValueWeighting ↓
DIKER MANAGEMENT LLC 1,028,295$45,183,00028.17%
NexWave Capital Partners LLC 84,802$3,751,0006.00%
Leonard Green & Partners, L.P. 2,600,000$114,244,0005.94%
Champlain Investment Partners, LLC 3,935,670$172,933,0001.18%
Aurora Investment Counsel 19,848$1,137,0000.94%
Brown Capital Management 2,531,558$111,237,0000.92%
Advantage Alpha Capital Partners LP 73,615$3,235,0000.75%
Conestoga Capital Advisors, LLC 789,154$34,675,0000.70%
WASHINGTON CAPITAL MANAGEMENT, INC 11,000$483,0000.50%
Intrinsic Edge Capital Management LLC 151,077$6,638,0000.45%
View complete list of CANTEL MEDICAL CORP shareholders